Carcinoid syndrome

From WikiAnesthesia
Revision as of 11:26, 3 May 2021 by Nirav Kamdar (talk | contribs) (Introduction and anesthetic implications)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Carcinoid syndrome is caused by neoplasms from neuroendocrine cells that can release vasoactive substances such as serotonin, histamine, dopamine, substance P, prostaglandins, and kallikreins. Systemic manifestations of circulating vasoactive peptides from carcinoid tumors include flushing, wheezing, and diarrhea in addition to hemodynamic changes such as hypertension and hypotension. Carcinoid syndrome can also exacerbate cardiac and right-sided valvular problems.

Carcinoid syndrome
Anesthetic relevance
Anesthetic management

{{{anesthetic_management}}}

Specialty
Signs and symptoms
Diagnosis
Treatment
Article quality
Editor rating
Unrated
User likes
0

Anesthetic implications

Preoperative optimization

Identify signs of carcinoid-induced cardiac disease and symptoms of neurpeptide release (as well as associated triggers)

Consider pre-operative echocardiography to assess right heart function and tricuspid valve

Intraoperative management

Postoperative management

Related surgical procedures

Pathophysiology

Signs and symptoms

Diagnosis

Treatment

Medication

Surgery

Prognosis

Epidemiology

References